Author

M. Bondarenko

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Organism:human· 1 Approach:statistical model· 1

Frequent Co-Authors

C. Carrere· 1 shared E. Pasquier· 1 shared G. Chapuisat· 1 shared M. Carre· 1 shared M. Le Grand· 1 shared M. Rossi· 1 shared M.-P. Montero· 1 shared N. Andre· 1 shared

Activity by Year

2021-2021 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

C. Carrere

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologybioRxivPreprintJan 4, 2021

Metronomic therapy prevents emergence of drug resistance by maintaining the dynamic of intratumor heterogeneity.

M. Bondarenko, M. Le Grand, Y. Shaked…·N. Andre

This study shows metronomic therapy better controls tumor heterogeneity than maximum-tolerated dose by leveraging drug-sensitive clones' suppressive effect on resistant ones through paracrine mechanisms.

DOI 10.1101/2021.01.04.425214

humanstatistical model

𝕏 PostBluesky